Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant gram-negative bacteria: Experimental and clinical evidence

Critical Care

Volumn 17, Issue 1, 2013, Pages

  Toufekoula, Chryssoula ^a   Papadakis, Vassileios ^a   Tsaganos, Thomas ^a   Routsi, Christina ^a   Orfanos, Stylianos E ^a   Kotanidou, Anastasia ^a   Carrer, Dionyssia Pinelopi ^a   Raftogiannis, Maria ^a   Baziaka, Fotini ^a   Giamarellos Bourboulis, Evangelos J ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE;

ACINETOBACTER BAUMANNII; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTICLE; BACTERIUM ISOLATE; CARDIOVASCULAR DISEASE; COLONY FORMING UNIT; CONTROLLED STUDY; HUMAN; KLEBSIELLA PNEUMONIAE; LIPID PEROXIDATION; LIVER; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RAT; SEPSIS; SPLEEN; SURVIVOR; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84872200123     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11930     Document Type: Article

References (24)

1. Belik J, González-Luis G, Perez-Vizcaino F, Villamor E. Isoprostanes in fetal and neonatal health and disease. Free Radical Biol Med 2010, 48:177-180.
2. Uchida K. 4-Hydroxy-2 nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003, 42:318-343. 10.1016/S0163-7827(03)00014-6, 12689622.
3. Azenabor AA, Mahony JB. Generation of reactive oxygen species and formation of membrane lipid peroxides in cells infected with Chlamydia trachomatis. Int J Infect Dis 2000, 4:46-50. 10.1016/S1201-9712(00)90066-3, 10689215.
4. Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anesth 2011, 107:57-64.
5. Gelaim DP, de Bittencourt Pasqual MA, Comim CM, Grunwald MS, Ritter C, Damiani Tomasi C, Cascaes Alves S, Quevedo J, Dal-Pizzol F, Donsace Moreira JC. Serum heat-shock protein 70 levels, oxidant status, and mortality in sepsis. Shock 2011, 35:466-470. 10.1097/SHK.0b013e31820fe704, 21330950.
6. Andersen M, Regueira T, Bruhn A, Perez D, Strobel P, Dougnac A, Marshall G, Leighton F. Lipoperoxidation and protein oxidative damage exhibit different kinetics during septic shock. Mediators Inflamm 2008, 168652.
7. Ware LB, Fessel JP, May AK, Roberts LJ. Plasma biomarkers of oxidant stress and development of organ failures in severe sepsis. Shock 2011, 36:12-17. 10.1097/SHK.0b013e318217025a, 3117035, 21372753.
8. Poulakou G, Kontopidou F, Paramythiotou E, Kompoti M, Katsiari M, Mainas E, Nicolaou C, Yphantis D, Antoniadou A, Trikka-Graphakos E, Roussou Z, Clouva P, Maguina N, Kanellakopoulou K, Armaganidis A, Giamarellou H. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. J Infect 2009, 58:273-284. 10.1016/j.jinf.2009.02.009, 19344841.
9. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy and outcome. Antimicrob Agents Chemother 2005, 49:760-766. 10.1128/AAC.49.2.760-766.2005, 547233, 15673761.
10. Teo J, Cai Y, Tang S, Lee W, Tan TY, Tan TT, Kwa AL. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study. PLoS One 2012, 7:e34254. 10.1371/journal.pone.0034254, 3312905, 22461908.
11. Giamarellos-Bourboulis EJ, Papadimitriou E, Galanakis N, Antonopoulou A, Tsaganos T, Kanellakopoulou K, Giamarellou H. Multidrug-resistance to antimicrobials as a predominant factor influencing patient survival. Int J Antimicrob Agents 2006, 27:476-481. 10.1016/j.ijantimicag.2005.12.013, 16707252.
12. Agarwal R, Chase SD. Rapid, fluorometric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr 2002, 775:121-126.
13. Giamarellos-Bourboulis EJ, Pechère JC, Routsi C, Plachouras D, Kollias S, Raftogiannis M, Zervakis D, Baziaka F, Koronaios A, Antonopoulou A, Markaki V, Koutoukas P, Papadomichelakis E, Tsaganos T, Armaganidis A, Koussoulas V, Kotanidou A, Roussos C, Giamarellou H. Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis 2008, 46:1157-1164. 10.1086/529439, 18444850.
14. Levy M, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
15. Spyridaki A, Raftogiannis M, Antonopoulou A, Tsaganos T, Routsi C, Baziaka F, Karagianni M, Mouktaroudi M, Koutoukas P, Pelekanou A, Kotanidou A, Orfanos SE, van der Meer JWM, Netea MG, Giamarellos-Bourboulis EJ. Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. Antimicrob Agents Chemother 2012, 56:3819-3825. 10.1128/AAC.05798-11, 3393410, 22564837.
16. Koussoulas V, Giamarellos-Bourboulis EJ, Adamis T, Mouktaroudi M, Sabracos L, Perrea D, Giamarellou H, Dionyssiou-Asteriou A. The significance of oxidant/antioxidant balance for the pathogenesis of experimental sepsis by multidrug-resistant Pseudomonas aeruginosa. Prostaglandins Leukot Essent Fatty Acids 2005, 72:41-47. 10.1016/j.plefa.2004.09.003, 15589398.
17. Alves-Filho JC, Spiller F, Cunha FQ. Neutrophils paralysis in sepsis. Shock 2010, 34(Suppl 1):15-21. 10.1097/SHK.0b013e3181e7e61b, 20714263.
18. Mohamandin AM, Elberry AA, Elkablawy MA, Gawad HAS, Al-Abassi FA. Monelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver. Pathophysiology 2011, 18:235-242. 10.1016/j.pathophys.2011.02.003, 21419608.
19. Yang Q, Mattick JSA, Orman MA, Nguyen TT, Ierapetritou MG, Berthiaume F, Androulakis IP. Dynamics of hepatic gene expression profile in a rat cecal ligation and puncture model. J Surg Res 2012, 176:583-600. 10.1016/j.jss.2011.11.1031, 22381171.
20. Smeding L, Leong-Poi H, Hu P, Shah Y, Haitsma JJ, Horvath E, Furmil S, Masoom H, Kuiper JW, Slutsky AS, Parker FB, dos Santos CC. Salutary effects of resveratrol on sepsis-induced myocardial depression. Crit Care Med 2012, 40:1896-1907. 10.1097/CCM.0b013e31824e1370, 22610192.
21. Zhang QS, Sadek H, Maass DL, Martinez B, Ma L, Kilgore JA, Williams NS, Frantz DE, Wigginton JG, Nwariaku FE, Wolf SE, Minei JP. Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in rat pneumonia-related sepsis model. Am J Physiol Heart Circ Physiol 2012, 302:H1847-H1859. 10.1152/ajpheart.00203.2011, 22408027.
22. Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R. Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007, 35:118-126. 10.1097/01.CCM.0000251124.83436.0E, 17095947.
23. Crimi E, Sica V, Williams-Ignaro S, Zhang H, Slutsky AS, Ignarro LJ, Napoli C. The role of oxidative stress in adult critical care. Free Radic Biol Med 2006, 40:398-406. 10.1016/j.freeradbiomed.2005.10.054, 16443154.
24. Kothari N, Keshari RS, Bogra J, Kohli M, Abbas H, Malik A, Dikshit M, Barthwal MK. Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis. J Crit Care 2011, 26:435.e1-435.e7.